Stealth BioTherapeutics Awarded Grant from The Michael J. Fox Foundation to Support Development of SBT-272 in Parkinson’s Disease
AP News,
NEEDHAM, Mass., Aug. 9, 2023 /PRNewswire/ -- Stealth BioTherapeutics, (the “Company” or “Stealth”), a clinical-stage…
Stealth BioTherapeutics Awarded Grant from The Michael J. Fox Foundation to Support Development of SBT-272 in Parkinson's Disease
WECT News 6,
NEEDHAM, Mass., Aug. 9, 2023 /PRNewswire/ -- Stealth BioTherapeutics, (the "Company" or "Stealth"), a clinical-stage…
Stealth BioTherapeutics Awarded Grant from The Michael J. Fox Foundation to Support Development of SBT-272 in Parkinson's Disease
14 News,
, - Stealth BioTherapeutics, (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery…